(E)-AG 556
CAS No. 133550-41-1
(E)-AG 556 ( (E)-Tyrphostin AG 556 )
Catalog No. M27474 CAS No. 133550-41-1
AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | Get Quote |
|
10MG | 72 | Get Quote |
|
25MG | 147 | Get Quote |
|
50MG | 222 | Get Quote |
|
100MG | 331 | Get Quote |
|
200MG | 489 | Get Quote |
|
500MG | 777 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(E)-AG 556
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
DescriptionAG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
Synonyms(E)-Tyrphostin AG 556
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133550-41-1
-
Formula Weight336.4
-
Molecular FormulaC20H20N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#C/C(/C(NCCCCc1ccccc1)=O)=C\c(cc1)cc(O)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qa'dan F, et al. Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo. J Ethnopharmacol. 2009 Jul 15;124(2):224-7.
molnova catalog
related products
-
Olmutinib
Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.?
-
Dihydroberberine
Dihydroberberine has anti-atherosclerotic anti-inflammatory hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG.
-
Alflutinib
Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.